The Importance of IGHV Mutational Status in Del(11q) and Del(17p) Chronic Lymphocytic Leukemia

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2011.12.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment of Patients With Chronic Lymphocytic Leukemia With 17p Deletion: The Saga Continues

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2011English

MYD88 Mutations Predict Unfavorable Prognosis in Chronic Lymphocytic Leukemia Patients With Mutated IGHV Gene

Blood Cancer Journal
OncologyHematology
2017English

Molecular Basis of Chronic Lymphocytic Leukemia: Correlation Between the Immunoglobulin Heavy Chain Mutational Status and the Expression of Apoptotic Genes

English

Externally Validated Predictive Clinical Model for Untreated Del(17p13.1) Chronic Lymphocytic Leukemia Patients

American Journal of Hematology
Hematology
2015English

Chemoimmunotherapy May Overcome the Adverse Prognostic Significance of 11q Deletion in Previously Untreated Patients With Chronic Lymphocytic Leukemia

Cancer
Cancer ResearchOncology
2008English

Chronic Lymphocytic Leukemia

Current Opinion in Hematology
Hematology
1998English

Chronic Lymphocytic Leukemia

Orvosi Hetilap
Medicine
2008English

Chronic Lymphocytic Leukemia

ASH Image Bank
2003English

Chronic Lymphocytic Leukemia

Molecular and Translational Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy